Crossmark

Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-019-3321-8

Published Online: 2019-06-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Scaioli, Eleonora

Belluzzi, Andrea

Ricciardiello, Luigi

Del Rio, Daniele

Rotondo, Enrica

Mena, Pedro

Derlindati, Eleonora

Danesi, Francesca https://orcid.org/0000-0002-4134-0066
Funding

Funding for this research was provided by:

Ministero dell’Istruzione, dell’Università e della Ricerca (RBSI14LHMB)
License Information

Text and Data Mining valid from 2019-06-06

Version of Record valid from 2019-06-06
More Information

Article History

Received: 13 May 2018

Accepted: 25 March 2019

First Online: 6 June 2019

Ethics approval and consent to participate

: The Ethics Committee of the St. Orsola-Malpighi Hospital (Bologna, Italy) approved the study on September 13, 2016 (89/2016/U/Sper). Written informed consent was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below